CRC Press, pp
Development and Expanding Indications of GLP-1 Receptor Agonists In 2005, the United States (US) Food and Drug Administration approved the first GLP-1 receptor agonist, exenatide, for the treatment of type 2 diabetes (T2D)
thyroid disorders), infection, surgery, or certain medication
From there, AgelessRx will notify you of your potential approval, and ship the medication to you directly
10.1186/s13287-017-0694-z Summary Keywords GLP-1, GLP-1RAs, T2DM, glucose, mechanism Citation He X, Zhao W, Li P, Zhang Y, Li G, Su H, Lu B and Pang Z (2025) Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus